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ABSTRACT 
 
Aim: This study aimed at calibrating a new set of GR-200A thermoluminescent 
dosimeters (TLDs) in low and medium kilovoltage energy photon therapy beams and in a 
diagnostic beam of known beam quality, in order to determine their response and to 
establish if the same set of TLDs could be used across both environments for in-vivo 
dosimetry purposes. 
 
Methods and Materials: A set of 20 TLDs was used for this study. An Oven type PCL3 
was used to anneal the TLDs. The response of the TLDs was read using the Reader type 
LTM manufactured by Harshaw Bicron, United State of America.  Vacuum tweezers 
were used to transfer the TLDs at the time of measurements and calibration. TLDs were 
kept in a subdued ultra-violet environment between the annealing and irradiation process. 
TLDs were placed on a 30 x 30 x 17.6 cm³ Polymethylmethacrylate (PMMA) phantom 
during irradiation. A calibrated Orthovoltage machine was used to deliver a known 
absorbed dose to the TLDs. A cylindrical ionization chamber (PTW 30001) and an 
electrometer (PTW 10008) were used to confirm the absorbed dose delivery of the 
orthovoltage machine at the time of measurement. Likewise, a calibrated LX40 
radiotherapy Simulator was used to deliver a known diagnostic absorbed dose to the 
TLDs. A TM77334 ionization chamber was used similarly to confirm the absorbed dose. 
The TLDs were also irradiated on the PMMA phantom. The accepted variation in raw 
response of the individual TLDs from the average of the batch was compared and a 
deviation of less than ± 20 % was considered within tolerance. A 10 % tolerance was 
subsequently considered suitable for the measurement of absorbed dose.   
 
Results: Of the 20 TLDs calibrated in the 95 kVp therapy beam (3 mm Al half-value 
layer), 17 were within the accepted response level (i.e. ± 20 % deviation), 17 in the 180 
kVp therapy beam (1 mm Cu half-value layer), 16 in the 300 kVp therapy beam (3 mm Cu 
half-value layer) and 15 in the diagnostic beam of 80 kVp (2.97 mm Al half-value layer). 
16 of the 17 TLDs were within ± 10 % dose tolerance at 95 kVp whereas all the TLDs 
that were within the accepted response level at the 180 kVp and 300 kVp,  were within the 
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± 10 % dose tolerance. 12 of the 15 TLDs at the diagnostic beam energy were within the 
± 10 % dose tolerance. Three of the TLDs were therefore rejected at all energies. 
 
Conclusion: The study concludes that the same set of GR-200A TLDs could be used 
across both kilovoltage therapy and diagnostic fluoroscopy environments for in-vivo 
dosimetry purposes if an accuracy of ± 10 % is considered acceptable, however a 
separate calibration needs to done at each beam quality. Individual dosimeters from a 
batch should be carefully identified and sorted during the calibration process prior to 
clinical use.  
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DEFINITION OF TECHNICAL TERMS, ACRONYMS AND SYMBOLS 
 
AAPM: American Association of Physicists in Medicine 
 
Absorbed Dose: The energy absorbed per unit mass of the irradiated material12. 
 
Annealing: The thermal treatment needed to erase the irradiation memory from a TLD. 
 
C: The unit of charge (coulombs) 
 
Calibration: The determination of the response or reading of an instrument relative to a 
series of known radiation values over the range of the instrument. 
 
cGy: Centi-gray (10-2 Gy) 
 
CT: Computed Tomography 
 
Dosimetry: The measurement of absorbed dose. 
 
ECC: Element Calibration Coefficient 
 
GR-200A: A Lithium Fluoride TLD doped with Magnesium, Copper, and Phosphorus.    
 
Gy: The unit of absorbed dose (gray) 
 
HVL: (Half-value layer) The thickness of an absorbing material (usually Al or Cu) 
necessary to reduce the air-kerma rate to 50 % of its original value in an X ray beam, in 
narrow beam conditions19. 
 
IAEA: International Atomic Energy Agency 
 
 xi
In-vivo dosimetry: The process of determining the absorbed dose to a patient undergoing 
radiation treatment through the use of radiation detectors placed on the patient during 
treatment. 
 
Irradiation: The exposure of matter to ionizing radiation. 
 
kV: kilovoltage 
 
MV: megavoltage 
 
nC: nano-coulombs (10-9 C) 
 
Phantom: A volume of material behaving in a manner similar to tissue with respect to the 
attenuation of radiation. 
 
PTW: Physikalisch Technische Werkstätten 
 
RCF: Reader Calibration Factor 
 
SD: Standard Deviation 
 
SSD: Source-Surface Distance 
 
TL: Thermoluminescence 
 
TLD: (Thermoluminescent dosimeter) crystalline materials that store absorbed energy on 
exposure to radiation and release it as visible light when exposed to heat. 
 
TLD-100: A TLD of Lithium Fluoride doped with Magnesium and Titanium. 
 
TLD-200: A TLD made up of Calcium fluoride. 
 xii
 
WHO: World Health Organization 
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1.0 INTRODUCTION 
 
When radiation is prescribed to a cancer patient, it is important that it is confirmed 
independently that the patient actually receives the dose prescribed.  In the words of Peter 
Nette and Hans Svensson “In principle, a quality assurance programme should ensure 
that all patients treated with a curative aim receive the prescribed dose within a margin of 
about 5%”1. In-vivo dosimetry is a method to determine if the patient receives the actual 
dose prescribed. 
 
At the Charlotte Maxeke Johannesburg Academic Hospital, GR200A and TLD-100 
TLDs are used for in-vivo dosimetry of patients undergoing radiation treatment. These 
TLDs are calibrated and implemented clinically for the high-energy photon beams. No 
calibrations have been done yet for the low and medium energy photon therapy beams 
and therefore, the response of the TLDs in this range is unknown at this stage. No in-vivo 
dosimetry has been performed in diagnostic beams either. 
 
In this study, GR-200A TLDs were calibrated in low and medium energy photon therapy 
beams and in a diagnostic beam of known beam quality, in order to determine their 
response and to establish if the same set of TLDs could be used across both kilovoltage 
environments for in-vivo dosimetry purposes. 
 
1.1 Background  
 
Radiation Oncology employs ionizing radiation in the treatment of cancerous cells. Two 
methods (teletherapy and brachytherapy) are used to deliver the ionizing radiation to the 
target volume. Teletherapy is a term used to describe treatments in which the source of 
radiation is distant from the patient12. Brachytherapy is a method of treatment in which 
radioactive sources are used to deliver radiation at a short distance by interstitial or 
surface applications12. A quality assurance programme ensures that all treatment facilities 
used in radiotherapy are properly checked for accuracy or consistency, that all radiation 
 2
facilities are functioning according to manufacturer’s specification and it includes 
mechanical and dosimetric tests. 
 
Dosimetry deals with methods for the quantitative determination of absorbed dose in a 
given medium by directly or indirectly ionizing radiation18. A dosimeter is the device or 
system that measures the absorbed dose either directly or indirectly18. In order for an 
instrument to function as a dosimeter, it must possess at least one physical property of the 
measured dosimetric quantity. Different types of dosimeters are used currently for the 
measurement of absorbed dose and these include ionization chambers, semiconductor 
dosimeters (e.g. diodes), film, alanine, gel, and thermoluminescent dosimeters. While 
some of these dosimeters are reusable (ionization chamber, TLDs, diodes) others are not 
(films, gels, and alanine)18. These dosimeters are calibrated from time to time to ensure 
consistency.   
 
1.2 TLDs and their properties  
 
1.2.1 Description of TLDs  
 
Thermoluminescent dosimeters are crystalline materials that store absorbed energy from 
exposure to radiation and release it as visible light when exposed to heat. TLDs have 
been used widely for different studies (in-vivo, in-phantom and environmental) 14, 15, 17. 
TLDs have the advantage of long-term stability6, 13 and low cost of acquisition compared 
to other detectors such as diodes11. TLDs are used for in-vivo dosimetry primarily 
because of their small size. TL materials are available in various forms i.e. chips, ribbons, 
discs, rods and powder.  
 
1.2.2 Interaction of radiation with TLDs 
 
The interaction process between radiation and TLDs occurs in two stages. The processes’ 
occurring within these two stages is diagrammatically shown in figure 1. 
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Figure 1:  The energy-level diagram of the thermoluminescence process21   
 
 
Irradiation stage: The ionization events triggered by irradiation begin with the elevation 
of electrons to the conduction band where they are trapped. The holes left behind migrate 
to hole traps, which are deep enough to prevent the escape of charge carriers (electrons 
and holes) for an extended period of time. 
 
Thermoluminescence stage: At sufficient temperature the electrons are released from 
their traps to recombine with the holes accompanied by the release of light photons 
(thermoluminescence).  
 
A glow curve is a plot of the total light emitted as a function of temperature. It contains 
several peaks, with each peak representing an intensity level. A sample of a glow curve is 
shown in figure 2.       
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Figure 2: Sample of a glow curve10 
 
1.2.3 Types of TL material 
 
An important characteristic of TLDs is their applicability to different environments 
owing to the variety of TL materials available. Several materials have been used in the 
production of TLDs (e.g. LiF: Mg, Ti, LiF: Mg, Cu, P, Li2B4O7: Mn, CaF2: Mn, Li2B4O7: 
Cu, Al2O3: C, CaSO4: Dy, CaF2: Dy) 8, 13. Of these TL materials, the most commonly 
used ones are the lithium fluorides2, 3, 5, 6,.Table 1 shows different TL materials and their 
characteristics. 
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Table 1: Dosimetric characteristics of selected TL materials13   
 
                                                                                                                                         
 
TL 
materials    
Form Glow 
peak 
(˚C)       
   Emission 
   maximum   
      (nm)         
Zeff Relative   
Sensitivity 
Linear    
Range 
(Gy)                  
Fading Annealing 
(Temperature 
and Time)                              
LiF: Mg, Ti Powder, chips, 
rods, discs. 
210 425 8.14 1 5 x 10-5 
to 1 
< 5 % 
per year 
400 ˚C, 1 h + 
80˚C, 24 h 
LiF: Mg, Ti, 
Na 
Powder, discs.  220 400 8.14 0.50  N/A 500 ˚C, 0.5 h 
LiF:Mg, Cu, 
P 
Powder, discs, 
chips 
232 310 (410) 8.14 15-30 10-6 to 12 < 5 % 
per year 
240 ˚C, 10 min 
Li2B4O7: Mn Powder 210 600 7.40 0.15-0.40 10-4 to 3 5 % in 2 
months 
300 ˚C, 15 min 
Al2O3: C Powder, discs 250 425 10.20 30 10-4 to 1 3 % per 
year 
300 ˚C, 30 min 
CaSO4: Dy Powder, discs 220 480 (570) 15.30 30-40 10-6 to 30 7-30 % 
in 6 
months 
400 ˚C, 1 h 
CaF2: Dy Powder 200 
(240) 
480 (575) 16.30 16 10-5 to 10 25 % in 
4 weeks 
600 ˚C, 2 h 
BeO Discs. 180-
220 
330 7.13 0.70-3 10-4 to 
0.50 
7 % in 2 
months 
600 ˚C, 15 min 
 
It can be observed from Table 1 that all lithium fluoride TLDs have the same effective 
atomic mass (Zeff) and fading periods but differ in relative sensitivity. The LiF: Mg, Cu, P 
TLD is of the highest relative sensitivity and it is available in different shapes of different 
dimensions as shown in Table 2.   
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Table 2: A list of LiF: Mg, Cu, P TLDs and their technical specifications8     
 
Part no. Material Type Dimensions Linear response 
GR200A LiF: Mg, Cu, P Circular chips 4.5 mm diameter x 
0.8 mm 
1 x 10-6 to 12 Gy 
GR200 LiF: Mg, Cu, P Square chips 3.2 x 3.2 x 0.9 
mm3 
1 x 10-6 to 12 Gy 
GR200R4 LiF: Mg, Cu, P Square micro rods 1 x 1 x 4 mm3 1 x 10-6 to 12 Gy 
GR200R1 LiF: Mg, Cu, P micro cubes 1 x 1 x 1 mm3 2 x 10-6 to 12 Gy 
GR200P LiF: Mg, Cu, P Powder 80 to 200 10-6 m 1 x 10-6 to 12 Gy 
GR200F LiF: Mg, Cu, P Film 4.5 mm diameter x 
0.125 mm 
1 x 10-6 to 12 Gy 
GR206A 6- LiF: Mg, Cu, P Circular chips 4.5 mm diameter x 
0.8 mm 
1 x 10-6 to 12 Gy 
GR206P 6- LiF: Mg, Cu, P Powder 80 to 200 10-6 m 1 x 10-6 to 12 Gy 
GR207A 7- LiF: Mg, Cu, P Circular chips 4.5 mm diameter x 
0.8 mm 
1 x 10-6 to 12 Gy 
GR207P 7- LiF: Mg, Cu, P Powder 80 to 200 10-6 m 1 x 10-6 to 12 Gy 
 
1.3 Historical review of the calibration of TLDs 
 
Different procedures have been employed in the handling and evaluating of TL materials 
2,3,4,5
. Coudin and Marinello3 calibrated a set of TLDs to be used for the measurement of 
back scatter factors, by irradiating Li2 B4 O7: Cu TLDs in diagnostic beams of 20, 40, 70, 
80 and 100 kVp. The response measured by the TLDs was obtained from an automatic 
TLD reader FIMEL type PCL, based on isothermal heating kinetics. The results obtained 
were then compared to Monte Carlo calculated data (reference data). The advantage of 
their calibration technique lay in the energy range used for the irradiation of the TLDs. 
The TLDs were however not calibrated in kilovoltage therapy beams.  
 
Nunn et al.2 calibrated a set of TLDs (TLD-100) for brachytherapy by irradiating them 
with moderately filtered therapy X-ray beams (20-250 kVp) and with a 60Co source. The 
response obtained was compared to Monte Carlo calculated data. The study showed that 
there was poor agreement between the measured response and the Monte Carlo calculated 
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response using the mass-energy absorption coefficients of pure Lithium Fluoride.  The 
study did not show if the set of TLDs could also be used in the diagnostic environment.   
 
Perisinakis et al.9 calibrated TLD – 100 and TLD – 200 TLDs to investigate the response 
of a pencil ionization chamber for the measurement of dose – width product (DWP) from 
diagnostic exposures. The TLD calibration was performed against a 3 cm3 Radcal 2025 
ionization chamber by simultaneously exposing the chamber and the TLDs to a 70 kVp 
beam on a radiographic X-ray unit. The TLD signal was then measured using a Victoreen 
2800 – M reader. Their report did not indicate how the 3 cm3 Radcal 2025 ionization 
chamber had been calibrated. Their study concluded that the DWP values measured using 
the TLDs were up to 11 % less than the corresponding values determined using the pencil 
ionization chamber. 
 
Daibes Figueroa et al.4 gave a detailed calibration process for 90 TLD-100 TLDs used for 
mouse dosimetry with micro CT imaging. The TLDs were first calibrated using a Cs-137 
reference check source. Of the 90 TLDs, only 24 TLDs had an 8 % sample-to-sample 
uniformity. Their study showed that there was a 40 % over response of the TLDs when 
they were calibrated using an X-ray source (diagnostic energy range). However, the type 
of TLD material may have influenced the over response as studies have shown that TLD-
100 is not suited to low energy photon beam dosimetry6, 7. Duggan6 compared the 
response of different TL materials in low energy photon therapy beams and showed that 
GR200A had a better response than TLD-100. Glenin7 also showed in a separate report 
that GR200A releases 34 times more light than TLD-100 when calibrated in low energy 
photon therapy beams.  
 
1.3.1 Factors affecting the response of TLDs 
 
The following are some of the factors that may affect the response of TLDs in the 
measurement of absorbed dose. 
•  The response of TLDs varies from one material to another 8, 13. 
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• The fading period for TLDs differs between materials as indicated in Table 1 and 
this may affect the response of TLDs. 
• Handling procedures8 (such as keeping TLDs under subdued ultra-violet 
environment during measurement, use of vacuum tweezers for transferring 
TLDs), if not followed properly during calibration of TLDs, may affect response.  
• Intrinsic response of the TLD reader may also affect the general response of the 
dosimeter16, 20.    
• The annealing used to prepare the TLDs for reuse may also influence the 
measurements as annealing regimes are different from one TL material to 
another8. 
 
TLD dosimetry is regarded as a ‘black art’ because to some, it produces excellent results 
with great accuracy but to others, all attempts seem to fail11. It is therefore necessary for 
each Radiotherapy centre to embark in a full dosimetric study for the calibration of TLDs 
before they are used clinically for in-vivo dosimetry.  
 
1.4 Research objective 
  
1. To calibrate a set of new GR200A TLDs (LiF: Mg, Cu, P) needed for in-vivo 
dosimetry in a range of kilovoltage therapy beams and in a diagnostic beam. 
2. To compare the absorbed dose obtained from 4 different beam qualities to an 
independently confirmed reference dose.  
3. To establish if the same set of TLDs could be used across both kilovoltage 
environments for in-vivo dosimetry purposes. 
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2.0 MATERIALS AND METHODS 
 
2.1 Study materials 
 
2.1.1 Detectors 
 
20 TLDs manufactured by FIMEL, France were used for this study. The TLDs were in 
the form of circular chips with dimensions 4.5 mm diameter and 0.8 mm thickness. The 
TLDs were kept in a subdued ultra-violet environment during storage. The same set of 
TLDs was used for all the different energies. The 20 TLDs were used both as calibration 
dosimeters and field dosimeters. This TL material was chosen for this study because of 
its availability, its high response in low energy photon beams and its proven use in high-
energy beams for clinical in-vivo dosimetry.6, 7, 17. The set of TLDs were arranged in an 
annealing pan prior to annealing for individual identification and then transferred to a 
plastic holder prior to irradiation to preserve the order of identification as shown in 
Figure 3. 
 
 
 
 
Figure 3: TLDs arranged in an annealing pan and in a plastic holder  
Annealing 
Pan TLDs 
TLDs 
Holder TLDs 
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A calibrated cylindrical ionization chamber (PTW 30001) and an electrometer (PTW 
10008) were used to verify the output of the orthovoltage machine. The consistency of 
the ionization chamber was confirmed using a Strontium–90 check source. The ionization 
chamber and the electrometer used are shown in Figure 4. A calibrated TM77334 
ionization chamber along with a T10008 electrometer was used to confirm the output of 
the radiotherapy simulator. The ionization chamber and the electrometer are also shown 
in Figure 4. 
 
 
 
 
 
 
Figure 4: The PTW 10008 electrometer, PTW 30001 Cylindrical ionization chamber, 
TM77334 ionization chamber and T10008 electrometer that were used to confirm the 
output of the orthovoltage machine and the radiotherapy simulator respectively. 
  
2.1.2 Annealing materials 
 
A type PCL3 Oven manufactured by PTW-Freiburg, Germany was used to anneal the 
TLDs. A photograph of the oven is shown in Figure 5. The parameters for the 
PTW 30001 
Cylindrical 
ionization chamber 
TM77334 
ionization 
chamber 
T10008 
electrometer 
PTW 10008 
electrometer  
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Temperature Time Profile (TTP) were set as indicated in the TL Detector User manual8 
and are shown in Table 3. An appropriate TTP for the TL material being used was set 
according to the parameters shown in Table 3.  
 
Figure 5: The Oven used to anneal the TLDs 
 
Table 3: Parameters for the Temperature Time Profile. 
 
Parameters GR200A 
Preheat Temperature 50 ˚C 
Preheat Time                                 0 s 
Acquire rate                                         10 ˚C/s 
Acquire max. Temperature           245 ˚C 
Acquire Time                                26 s 
Anneal Temperature                    240 ˚C 
Anneal Time                                  0 s 
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A Vacuum tweezer DYMAX 30 was used to transfer the TLDs during measurement and 
calibration. The Vacuum tweezer is shown in Figure 6. 
 
Figure 6: The Vacuum tweezer DYMAX 30 that was used to transfer the TLDs during 
measurement. 
 
2.1.3 Reader  
 
The response of the TLDs was read using the Reader type LTM. The automatic mode of 
the reader was used during readout. The Element Correction Coefficient (ECC) 
determines the response range of the TLDs and is generated as follows10: 
            ECC = <Q> ÷ Qi………………………………………………………………....(1) 
Where, 
 <Q> is the average charge integral of the TLDs and 
   Qi is the individual charge integral of the TLDs 
The ECC range was set between 0.90 Gy to 1.10 Gy10 (i.e. ± 10 % deviation) for the 
calibration dosimeters and between 0.80 Gy to 1.20 Gy10 (i.e. ±20 % deviation) for the 
field dosimeters during the experimental process. The Reader was calibrated by selecting 
the set of TLDs that were within the ECC range for calibration dosimeters (to generate 
the Reader Calibration Factor, RCF). The RCF was generated as follows: 
               RCF = <Qc> ÷ D…………………………………………………………….(2) 
 Where,    
<Qc> is the average corrected charge integral and 
  D is the absorbed dose (1.00 Gy) delivered to the TLDs10. 
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The Reader used is shown in Figure 7. 
 
Figure 7: The reader type LTM that was used to read the TLDs 
 
The Oven and the Reader were connected to a dedicated personal computer that used 
Theldo and WinRems software for initiating the annealing and reading programs 
respectively. 
 
2.1.4 Radiation facilities 
 
A calibrated orthovoltage machine manufactured by Gulmay, Germany was used to 
deliver 1.00 Gy to the TLDs.  A calibrated Toshiba LX40 radiotherapy simulator, Japan 
was used to deliver a known diagnostic dose of 1.00 cGy to the TLDs. The TLDs were 
placed on the surface of a 30 x 30 x 17.6 cm³ Polymethylmethacrylate (PMMA) phantom 
during both irradiations. A radiographic film was used to check the dose uniformity of 
the absorbed dose delivered. 
 
 
 
TLD in reading 
position 
Planchet 
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2.2 Data collection procedures 
 
2.2.1 Absorbed dose delivery verification procedure at orthovoltage 
 
The absorbed dose delivered by the orthovoltage machine was determined using the in-
phantom method described in the American Association of Physicists in Medicine Task 
Group 6119. The chamber was placed at a depth of 2 cm. A 10 x 10 cm² applicator was 
used to define the field size at 50 cm SSD. Different filters with varying thicknesses were 
used to harden the beams. The machine monitor unit (time) was calculated to deliver a 
dose of 1.00 Gy at the surface. A photograph of the experimental set-up is shown in 
Figure 8.  
 
Figure 8: Experimental set-up for absorbed dose delivery verification at orthovoltage. 
 
 
PMMA phantom 
Chamber at 2 cm depth 
10 x 10 cm² applicator 
50 cm SSD 
Filter 
Treatment Head 
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The absorbed dose to the phantom at the depth of 2 cm was calculated using the formula; 
 
, 2 ,
w
en
W Z cm K Q chamb sheath
air
water
UD MN P P
ρ=
  
 =  
   
……………………………………………..(3) 
Where, 
M is the electrometer reading (charge) corrected for temperature and pressure. 
Nk is air-kerma calibration factor, for a specified X ray beam quality. 
PQ,chamb is the overall  chamber  correction factor that accounts for the change due to the 
change in beam quality between calibration and measurement and to the perturbation of 
the photon fluence at the point of measurement by the chamber, and the chamber stem, 
which is dimensionless.                                                     
Psheath is the correction for photon absorption and scattering in the waterproofing sleeve. 
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ρ
is the mean mass-energy absorption coefficient ratio for water to air 
averaged over the photon spectrum at the reference point in water in the absence of the 
chamber. 
 
The absorbed dose at the depth of 2 cm was then converted to absorbed dose at the 
surface of the phantom by using the percentage depth dose (PDD). This was done for the 
95 kVp (3.00 mm Al HVL), 180 kVp (1.00 mm Cu HVL), and 300 kVp (3.00 mm Cu 
HVL) therapy beams. 
 
2.2.2 Confirmation of reference absorbed dose at the simulator 
 
The reference absorbed dose to be delivered to the TLDs in the diagnostic beam was 
determined using the in-phantom formalism described in IAEA Technical Report Series 
457 for calculating the entrance surface air kerma rate13. The fluoroscopic mode of the 
radiotherapy simulator was used. The TLDs were exposed to an 80 kVP beam of 2.97 mm 
Al HVL. The simulator was set to a fluoroscopic time of 30 s and tube loading of 40 
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mAs. A field size of 25 x 25 cm² at 100 cm focus to table top was used. A reference dose 
of 1.00 cGy was delivered to the ionization chamber at the surface of the PMMA 
phantom as shown in Figure 9. 
  
 
Figure 9: Experimental set-up for reference absorbed dose in simulator 
 
The entrance surface air kerma rate was calculated using the formula; 
Ќe = (M Nk, Q. KQ Bw) / (BPMMA)……………………………………………………..….(4) 
Where; 
M is the electrometer reading (charge), with the centre of the sensitive air cavity placed at 
the surface, corrected for temperature and pressure. 
Nk, Q. is the chamber calibration coefficient 
Image 
Intensifier 
PMMA phantom 
Chamber at surface 
of the phantom 
100 cm focus to 
table top 
X ray tube 
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KQ is the factor which corrects for difference in the response of the dosimeter at the 
calibration quality, Q., and at quality, Q of the clinical X ray beam.  
Bw is the back scatter factor in terms of air kerma for water 
BPMMA is the back scatter factor in terms of air kerma for PMMA. 
The entrance surface air kerma rate was obtained in cGy (The term entrance surface air 
kerma rate was used to represent the absorbed dose in accordance with the protocol)13.  
 
 2.2.3 TLD calibration procedures at orthovoltage 
 
After irradiation, the TLD responses were read and stored in a database for calibration. 
EECs for the calibration dosimeters were generated from the database. Only TLDs that 
were within the ± 10 % accepted range for calibration dosimeters were selected for the 
calibration of the reader. The RCF was generated from the data base by applying the 
EECs of calibration dosimeters generated above. The RCF was then stored for future use.  
 
The field dosimeter ECCs were generated by applying the RCF and setting the ECC 
range to the ± 20 % accepted range for field dosimeters. All TLDs that were within the 
accepted range were kept for calibration while others (marked as bad dosimeters) were 
removed from the batch. The absorbed dose measured was obtained by applying the RCF 
and the individual ECCs of the TLDs. The absorbed dose obtained was then stored for 
analysis. After the calibration process had been completed, the TLDs were irradiated 
again to an arbitrary absorbed dose of 2.00 Gy and read. 
 
2.2.4 TLD calibration procedures at the simulator 
 
The data collection procedures were repeated with the same set of TLDs for an absorbed 
dose of 1.00 cGy from the simulator. After the calibration process had been completed, 
the TLDs were irradiated to an arbitrary absorbed dose of 2.00 cGy and read.  
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3.0 RESULTS AND DISCUSSION 
 
3.1 Absorbed dose delivery verification results at orthovoltage 
 
The absorbed dose at the surface derived from the ionization chamber measurement at the 
3 kilovoltage therapy beams, was 1.00 ± 0.01 Gy. 
 
3.2 TLD calibration results at orthovoltage 
 
At the start of the experiment, a calibration was performed in the 95 kVp therapy beam to 
generate an RCF file. 20 TLDs were irradiated to known absorbed doses in the 180 kVp 
and 300 kVp therapy beams. Only 40 % of the TLDs were within ± 10 % of the delivered 
absorbed dose in the 180 kVp beam and only 25 % in the 300 kVp beam. Separate RCF 
file were therefore generated for each beam quality. 
 
 95 kVp  
 
7 of the TLDs had a raw response that were out of range (i.e. more than ± 10 %) and were 
therefore not used as calibration dosimeters. The RCF value was calculated to be 0.39 nC 
/ Gy. 3 of the TLDs had ECCs that were out of the accepted range (i.e. ± 20 %) and were 
discarded. The remaining TLDs were all within ± 10 % of the 1.00 Gy delivered, except 
TLD D3 as shown in Table 4. For the 2.00 Gy irradiation, all TLDs were within ± 10 %.  
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Table 4: The results of TLDs exposed to an absorbed dose of 1.00 and  
2.00 Gy in the 95 kVp therapy beam. 
 
Dosimeter ID Absorbed dose 
(Gy) 
(1 Gy irradiation) 
Absorbed dose 
(Gy) 
(2 Gy irradiation) 
C3 0.93 1.95 
C4 0.96 1.97 
C6 0.92 1.90 
C7 0.91 1.92 
D3 0.89 1.92 
D4 0.91 1.93 
D5 0.94 1.96 
D6 0.95 1.96 
D7 0.95 1.97 
E3 0.93 1.91 
E4 0.91 1.93 
E6 0.94 1.96 
E7 0.94 1.95 
F4 0.93 1.92 
F5 0.95 1.96 
F6 0.95 1.97 
F7 0.92 1.91 
Mean ± SD 0.93 ± 0.02  1.94 ± 0.02 
    
 
180 kVp  
 
9 of the TLDs had a raw response that were out of range (i.e. more than ± 10 %) and were 
therefore not used as calibration dosimeters. The RCF value was calculated to be 0.30 nC 
/ Gy. 3 of the TLDs had ECCs that were out of the accepted range (i.e. ± 20 %) and were 
discarded. The remaining TLDs were all within ± 10 % of the 1.00 Gy delivered as 
shown in Table 5. For the 2.00 Gy irradiation, all TLDs were within ± 10 %.  
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Table 5: The results of TLDs exposed to an absorbed dose of 1.00 and  
2.00 Gy in the 180 kVp therapy beam. 
 
Dosimeter ID Absorbed dose (Gy) 
(1 Gy irradiation) 
Absorbed dose (Gy) 
(2 Gy irradiation) 
C3 1.05 2.01 
C4 1.07 2.09 
C6 1.03 2.05 
C7 1.00 2.01 
D3 1.06 2.08 
D4 1.04 2.06 
D5 1.06 2.07 
D6 1.03 2.05 
D7 1.05 2.03 
E3 1.05 2.08 
E4 1.05 2.06 
E6 1.05 2.06 
E7 1.08 2.05 
F4 1.08 2.06 
F5 1.09 2.08 
F6 1.04 2.02 
F7 1.04 2.04 
 Mean ± SD 1.05 ± 0.04 2.05 ± 0.03 
 
300 kVp  
 
9 of the TLDs had a raw response that were out of range (i.e. more than ± 10 %) and were 
therefore not used as calibration dosimeters. The RCF value was calculated to be 0.24 nC 
/ Gy. 3 of the TLDs had ECCs that were out of the accepted range (i.e. ± 20 %) and were 
discarded. The remaining TLDs were all within ± 10 % of the 1.00 Gy delivered as 
shown in Table 6. For the 2.00 Gy irradiation, all TLDs were within ± 10 %.  
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Table 6: The results of TLDs exposed to an absorbed dose of 1.00 and  
2.00 Gy in the 300 kVp therapy beam. 
 
Dosimeter ID Absorbed dose (Gy) 
(1 Gy irradiation) 
Absorbed dose (Gy) 
(2 Gy irradiation) 
C3 0.99 2.01 
C4 0.97 1.98 
C6 0.98 1.96 
C7 1.01 1.95 
D3 0.98 1.97 
D4 0.97 1.99 
D5 0.97 1.95 
D6 0.98 1.95 
D7 0.99 1.96 
E3 0.96 1.97 
P4 0.97 1.98 
E6 0.98 1.94 
F4 0.97 1.93 
F5 0.98 1.94 
F6 0.95 1.97 
F7 0.95 1.98 
 Mean ± SD 0.98 ± 0.02 1.96 ± 0.02 
  
3.3 Confirmation of reference absorbed dose result at simulator 
 
The absorbed dose measured by the ionization chamber at the kilovoltage diagnostic 
beam was 1.00 ± 0.01 cGy. 
 
3.4 TLD calibration results at the simulator 
 
8 of the TLDs had a raw response that were out of range (i.e. more than ± 10 %) and were 
therefore not used as calibration dosimeters. The RCF value was calculated to be 0.01 nC 
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/ Gy. 5 of the TLDs had ECCs that were out of the accepted range (i.e. ± 20 %) and were 
discarded. 12 of the TLDs were within ± 10 % of the 1.00 cGy delivered as shown in 
Table 7. For the 2.00 cGy irradiation, all TLDs were within ± 10 %.  
 
Table 7: The results of TLDs exposed to an absorbed dose of 1.00 and  
2.00 cGy in the 80 kVp diagnostic beam. 
 
Dosimeter ID Absorbed dose (cGy) 
(1 cGy irradiation) 
Absorbed dose (cGy) 
(2 cGy irradiation) 
C4 1.03 2.01 
C6 0.89 2.09 
C7 1.03 2.06 
D3 1.06 2.04 
D4 1.08 2.04 
D5 0.99 2.01 
D6 1.03 2.05 
D7 1.15 2.09 
E3 1.08 2.03 
E4 0.83 2.10 
E6 1.05 2.07 
F4 0.96 2.05 
F5 1.00 2.02 
F6 0.99 1.95 
F7 0.99 2.02 
 Mean ± SD 1.01 ± 0.08 2.04 ± 0.04 
 
Overall, the results of the absorbed dose obtained when a separate RCF was generated for 
each beam quality showed that about 85 % of the TLDs produced results that were within 
± 10 %. In the fluoroscopic diagnostic beam, 3 (20 %) of the TLDs deviated more than ± 
10 %. This deviation could be due to experimental uncertainties. There was no significant 
deviation from linearity in the response when the TLDs were exposed to 2.00 Gy from 
the therapy beams and 2.00 cGy from the diagnostic beam. 
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In this study, separate calibrations of the TLDs in each beam quality have been employed 
to overcome energy dependence of the TLDs. The generation of a separate calibration 
factor (RCF) for each beam quality improved the overall result compared to a single 
calibration factor. No correction factors derived from published models26 were applied in 
this work.  The TLDs were also given a known absorbed dose in the 300 kVp therapy 
beam and then read using the RCF of the 180 kVp therapy beam. 60 % of the TLDs were 
within the ± 10 % of the absorbed dose delivered. This shows that the use of a single 
calibration factor used across medium energy beams could be investigated further.  
 
In general, the results confirm that the TLDs are energy dependent. This result agrees 
with that of Krasa et al.22 who showed that GR200A TLDs were energy dependent. The 
ratio of stopping powers or mass energy absorption coefficients of TLD to water is often 
used to describe variation of TLD response with varying photon energy25. However, there 
are other factors that affect the variation of TLD response with energy such as the 
thickness of the TL material, texture (i.e. roughness or smoothness of the TLD surface) of 
the TL material and doping (i.e. mixture of different materials), which may make it 
difficult to accurately predict the variation of TLD response with energy theoretically. In 
some cases, the use of monoenergetic photon beams along with mathematical models 
have been employed to predict the energy dependence of TLD response 23,24.  Correction 
factors for different beam qualities have also been generated to compensate for this 
effect26. According to Kron et al.23, variation in TLD response could be due to the 
assumption that the response at low energies reduces exponentially whereas at medium 
energies, it varies according to the energy dependence from the photoelectric effect.   
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4.0 CONCLUSION 
 
1. The same set of GR-200A TLDs could be used across both kilovoltage therapy and 
diagnostic fluoroscopy environments for in-vivo dosimetry purposes if an accuracy of ± 
10 % is considered acceptable, however a separate calibration needs to be done at each 
beam quality. 
 
2. A further study into other fluoroscopic diagnostic beam qualities should be considered. 
 
3. A further study into the radiographic mode of the simulator and/or other diagnostic 
modalities should be considered also. 
 
4. Individual dosimeters from a batch should be carefully identified and sorted during the 
calibration process prior to use in the clinic for in-vivo dosimetry. 
 
5. An extended study into absorbed dose linearity behaviour should be considered as 
there is not enough data in this report to confirm this relationship. 
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